-
Ontario Tumour Bank collaborating to improve biobanking globally
Biorepositories (or biobanks) play an important role in many types of research.
-
OTB Oncology Future Needs Survey - Your Input Requested
The Ontario Tumour Bank is conducting a survey to better understand future biospecimen and data needs of oncology researchers.
-
Ontario Tumour Bank virtual lab tour: watch the video here
Have you ever wondered what it takes to become a gold-standard biobank?
-
Coming Soon! Have you heard about circulating nucleic acid plasma?
A NEW tool for early detection, diagnosis, prognosis and monitoring of human tumours.
-
Bob Phillips, Sugy Kodeeswaran, and others congratulate OTB on 10 years of biobanking: watch the video here.
Congratulations to the Ontario Tumour Bank on a successful first 10 years.
-
Ontario Tumour Bank to supply samples to COEUR, a pan-Canadian ovarian cancer research project
The Ontario Tumour Bank (OTB) will supply ovarian tumour samples to the Canadian Ovarian Cancer Experimental Unified Resource (COEUR) in an effort to further enhance ovarian cancer research in Canada, announced Dr. John Bartlett, Provincial Principal Investigator, OTB and Director of the Ontario Institute for Cancer Research’s (OICR) Transformative Pathology Program.
-
Becoming One Bank: A Multicenter Tumour Bank Servicing Ontario Province (Canada)
The Ontario Tumour Bank (OTB) is a program of the Ontario Institute for Cancer Research (OICR) in Ontario, Canada. We are a provincial biorepository funded by the Ministry of Economic Development and Innovation. Our program encompasses four large teaching hospitals across the province: The London Health Sciences Centre, St. Joseph’s Healthcare Hamilton, The Ottawa Hospital, and Kingston General Hospital. We focus on the collection of tumour and blood samples and related clinical data from over 30 types of cancers, and distributes these materials to qualified academic and industry researchers (www.ontariotumourbank.ca).
-
LHSC tumour bank providing support to cancer researchers around the world
For researchers across Canada, and around the world, obtaining high quality tumour samples for cancer research can be a challenge - particularly for rare cancer types. London Health Sciences Centre (LHSC) has been helping to address that challenge since 2004, collecting over one third of the tumour samples available to researchers through the Ontario Tumour Bank (OTB), a provincial biobank owned and managed by the Ontario Institute for Cancer Research, a not-for-profit organization. LHSC is one of four collection centres making up the OTB, which in May passed the 10,000 donor milestone.
-
Celebrating KGH's Tumour Bank
The Ontario Tumour Bank (OTB) is celebrating a milestone. It's now banked samples from more than 10,000 donors and Kingston General Hospital is a big part of that success.
Since the program began at our hospital in 2005, over 1,700 donors from Kingston and across the region have provided over 2,000 samples to it. -
Over 10,000 donors have now provided samples to the Ontario Tumour Bank
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR), today announced that the Ontario Tumour Bank (OTB) has now banked samples from more than 10,000 donors. This is an important milestone for the OTB, a province-wide biorepository and data bank led by OICR that is focused on the collection of tumour-related blood and tissue samples for cancer research.
Media Fact Sheet
For Researchers
The high-quality biospecimens, derivatives and clinical data are an important resource for scientists engaged in translational research who are developing better diagnostic tools and new drug therapies. Researchers can depend on OTB to provide products and services of high quality, diversity, and integrity.
For Patients
OTB is committed to ensuring that the collection of research biospecimens does not interfere with patient care and that the privacy and confidentiality of all volunteer donors are maintained. Informed consent for tissue collection and research use is obtained from all patients.